Tag: Lord Dholakia

The below Parliamentary question was asked by Lord Dholakia on 2016-01-26.

To ask Her Majesty’s Government how many prisoners have been tested for (1) hepatitis B, (2) hepatitis C, and (3) HIV, in each of the last three years.

Lord Prior of Brampton

Public Health England (PHE) collects data on people in prison tested for blood-borne viruses (BBVs) via the Sentinel Surveillance Study. This system does not currently receive reports from all prisons in England where testing occurs. Currently 28 prisons report data representing approximately 30% of the standing prison population in England so this data does not represent the total amount of testing currently happening in the prison estate.

Table 1 shows data from this system on the total number of prisoners tested for BBVs in the calendar years 2012-2014. Similar information from this study for the year 2015 will not be available until mid-year 2016. NHS England also collects data on levels of testing for BBVs in prisons via the Health & Justice Indicators of Performance (HJIPs). The numbers of tests for BBVs in these data are presented in Table 2. The higher number is due to the greater coverage of prisons by this dataset. NHS England data is not used for 2012, 2013 and 2014 is not available because HJIPs were only introduced last year.

The below Parliamentary question was asked by Lord Dholakia on 2016-01-26.

To ask Her Majesty’s Government what percentage of prisoners they plan to test for blood-borne viruses in each of the next five years, in the light of the introduction of opt-out testing in prisons.

Lord Prior of Brampton

Public Health England (PHE) working in partnership with NHS England and the National Offender Management Service (NOMS) have been implementing opt-out testing for blood-borne viruses (BBVs) since 2013/14 through a phased implementation programme using ‘pathfinder prisons’ with plans for the programme to be available in every adult prison in England by the end of financial year 2016/17. All consenting eligible adult prisoners will be offered the opportunity to test.

Prisoners eligible for testing include those not known to be infected with BBVs who have not been tested recently and/or who had risk behaviour since their last test. Therefore over the next five years and beyond, we plan to offer tests for BBVs to all adult prisoners who fall into these categories. Phased implementation of the BBV opt-out testing programme in prisons has been informed by evaluation of pathfinder prisons. Preliminary data from suggests a near doubling of BBV testing following the introduction of the opt-out testing policy. Offer, uptake and outcome of testing is being collected by both the Health & Justice Indicators of Performance at prison level as well as through PHE’s sentinel surveillance study.

The below Parliamentary question was asked by Lord Dholakia on 2016-01-26.

To ask Her Majesty’s Government how many individuals have commenced interferon-free treatment for hepatitis C within a prison or secure institution in the last 12 months.

Lord Prior of Brampton

NHS England collect data on the offer, uptake and outcome of testing for hepatitis C for people in prison using a system of metrics co-designed with Public Health England (PHE) called the Health & Justice Indicators of Performance (HJIPs). This dataset includes information on whether those requiring treatment were referred to specialist services but does not record details of the treatment provided.

PHE has been working with NHS England and Operational Delivery Networks (ODNs) and others on a dataset which would allow for more detailed monitoring of treatments but these have not yet been introduced. Therefore, we do not currently have any data on the number of individuals commenced on treatment for hepatitis C within a prison or other prescribed place of detention in the last 12 months. Further, we do not have data on those former prisoners commenced on treatment in the community.